5 Key Takeaways

• 1

  The gut microbiome significantly influences drug absorption, metabolism, and tolerance, impacting treatment efficacy and patient responses.

• 2

  Standardized microbiome testing is lacking, complicating drug development and predictive modeling due to individual variability and inconsistent methods.

• 3

  Recent advancements in microbiome science enable detailed mapping of microbial ecosystems, enhancing patient stratification and treatment personalization.

• 4

  Pharmacomicrobiomics reveals that gut microbes affect drug outcomes directly and indirectly, influencing both efficacy and side effects.

• 5

  Integrating microbiome insights into drug development can improve existing therapies and lead to novel, personalized treatments tailored to individual microbiomes.